Matching articles for "Thalitone"
Issue 1733 · July 21, 2025 Free
In Brief: Low-Dose Chlorthalidone (HemiClor) for Hypertension

The FDA has approved a 12.5-mg tablet formulation of the thiazide-like diuretic chlorthalidone ( HemiClor – Ingenus) for treatment of hypertension. Chlorthalidone has been available for years in 15-, 25-,…

Med Lett Drugs Ther. 2025 Jul 21; 67(1733):118 doi:10.58347/tml.2025.1733e
The FDA has approved a 12.5-mg tablet formulation of the thiazide-like diuretic chlorthalidone ( HemiClor – Ingenus) for treatment of hypertension. Chlorthalidone has been available for years in 15-, 25-, and 50-mg tablets ( Thalitone , and generics) and in fixed-dose combinations with azilsartan medoxomil (Edarbyclor) and atenolol ( Tenoretic , and generics).
Issue 1703 · May 27, 2024
Drugs for Hypertension

American College of Cardiology/American Heart Association (ACC/AHA) guidelines for treatment of hypertension were last published in 2018. Treatment of hypertensive urgencies and emergencies is not discussed…

Med Lett Drugs Ther. 2024 May 27; 66(1703):81-8 doi:10.58347/tml.2024.1703a
American College of Cardiology/American Heart Association (ACC/AHA) guidelines for treatment of hypertension were last published in 2018. Treatment of hypertensive urgencies and emergencies is not discussed here.
Issue 1385 · March 5, 2012
Edarbyclor: An ARB/Chlorthalidone Combination for Hypertension

The FDA has approved a fixed-dose combination of the angiotensin receptor blocker (ARB) azilsartan and the thiazide-like diuretic chlorthalidone as Edarbyclor (Takeda) for treatment of hypertension

Med Lett Drugs Ther. 2012 Mar 5; 54(1385):17-8
The FDA has approved a fixed-dose combination of the angiotensin receptor blocker (ARB) azilsartan and the thiazide-like diuretic chlorthalidone as Edarbyclor (Takeda) for treatment of hypertension
Issue 113 · January 1, 2012
Drugs for Hypertension

Drugs available in the US for treatment of chronic hypertension, with their dosages and adverse effects, are listed in the tables that begin on page 2. Combination products are listed on page 8. Drugs for…

Treat Guidel Med Lett. 2012 Jan; 10(113):1-10
Drugs available in the US for treatment of chronic hypertension, with their dosages and adverse effects, are listed in the tables that begin on page 2. Combination products are listed on page 8. Drugs for treatment of hypertensive emergencies are not discussed here. They were reviewed previously.
Issue 77 · January 1, 2009
Drugs for Hypertension

Drugs available in the US for treatment of chronic hypertension, with their dosages, adverse effects and costs, are listed in the tables that begin on page 2. Combination products are listed on page 9. Drugs…

Treat Guidel Med Lett. 2009 Jan; 7(77):1-10
Drugs available in the US for treatment of chronic hypertension, with their dosages, adverse effects and costs, are listed in the tables that begin on page 2. Combination products are listed on page 9. Drugs for treatment of hypertensive emergencies are not discussed here. They were reviewed in Treatment Guidelines ( volume 1, page 19, December 2002 ) and in The Medical Letter ( volume 50, page 73, September 22, 2008 ).
Issue 34 · June 1, 2005
Drugs for Hypertension

Drugs available in the US for treatment of chronic hypertension, with their dosages, adverse effects and costs, are listed in the tables that begin on page 40. Combination products are listed on page 47. Drugs…

Treat Guidel Med Lett. 2005 Jun; 3(34):39-48
Drugs available in the US for treatment of chronic hypertension, with their dosages, adverse effects and costs, are listed in the tables that begin on page 40. Combination products are listed on page 47. Drugs for treatment of hypertensive emergencies are not discussed here.
Issue 768 · June 17, 1988
Microx

Microx (Pennwalt), a new low-dosage formulation of the thiazide-type diuretic metolazone ( Zaroxolyn ; Diulo ), was recently marketed in the USA. The manufacturer claims that the low dose of controls…

Med Lett Drugs Ther. 1988 Jun 17; 30(768):63-4
Microx (Pennwalt), a new low-dosage formulation of the thiazide-type diuretic metolazone ( Zaroxolyn ; Diulo ), was recently marketed in the USA. The manufacturer claims that the low dose of controls hypertension with less potassium loss, making it safer than other diuretics and as effective as combination drugs, such as Dyazide , that include both a thiazide and a potassium-sparing diuretic. Medical Letter consultants generally do not recommend Dyazide or other fixed-dose combinations for treatment of hypertension.